Hemophilia Drug Development (HDD 2020)

  • 18-20 Aug 2020
  • Hyatt Regency Boston, MA, United States


Hemophilia Drug Development (HDD 2020) is a conference dedicated to the most pressing challenges in the broad spectrum of novel therapies in the treatment of hemophilia.

Hemophilia Drug Development (HDD 2020) covers topics such as:

  • Mechanisms in next generation therapies to understand the biological impacts
  • Optimizing patient-centric approaches to ensure patient engagement
  • How to define endpoints in the era of new drugs
  • The factors that influence patients to adopt novel therapies

Hemophilia Drug Development (HDD 2020) will be held in Boston, MA, United States on 18-20 Aug 2020.


Hyatt Regency Boston
1 Avenue De Lafayette,
United States
View Hotels near Venue
Free cancellation available

More Details

1199-2998 US Dollar
No exhibition
Hanson Wade

Future Events

  • Hemophilia Drug Development (HDD 2020) - 18-20 Aug 2020, Hyatt Regency Boston, Boston, MA, United States (84616)
  • Hemophilia Drug Development (HDD 2021) - Aug 2021, Boston, MA, United States (75995)

Past Events

  • Hemophilia Drug Development (HDD 2019) - 20-22 Aug 2019, Wyndham Boston Beacon Hill, Boston, MA, United States (84615)


Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories

Featured Conferences & Exhibitions